Oncology News Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
BusulfanOncology News Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally
5-FUOncology News Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy
Oncology NewsPaclitaxel Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel
Oncology NewsPaclitaxel Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy
Oncology NewsPaclitaxel Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting
5-FU Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting
ImatinibOncology News Saladax Biomedical Announces U.S. Launch of MyImatinib™ Chemotherapy Exposure Optimization Test
